Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Bile duct stone
ADR ID BADD_A00450
ADR Hierarchy
09      Hepatobiliary disorders
09.02      Bile duct disorders
09.02.02      Obstructive bile duct disorders (excl neoplasms)
09.02.02.003      Bile duct stone
Description Presence or formation of GALLSTONES in the COMMON BILE DUCT. [MeSH]
MedDRA Code 10004637
MeSH ID D042883
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Bile duct stone | Bile duct stone with cholecystitis | Bile duct stone with cholecystitis, obstructive | Calculus common bile duct | Calculus cystic duct | Calculus of bile duct with other cholecystitis | Calculus of bile duct with other cholecystitis, with obstruction | Calculus of bile duct with other cholecystitis, without mention of obstruction | Calculus of bile duct without mention of cholecystitis | Calculus of bile duct without mention of cholecystitis, without mention of obstruction | Common bile duct calculus | Common bile duct stone | Cystic duct stone | Stones common duct | Choledocholithiasis | Hepatolith | Intrahepatic stone | Cholelithiasis, Common Bile Duct
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00066Alendronic acid0.000303%
BADD_D00151Apixaban0.000662%
BADD_D00165Aripiprazole0.000381%
BADD_D00405Ceftriaxone0.234897%
BADD_D00480Clarithromycin0.001645%
BADD_D00564Dabigatran etexilate0.002637%
BADD_D00594Deferasirox0.005831%
BADD_D00734Duloxetine0.000132%
BADD_D00869Famotidine0.000262%
BADD_D01110Hydroxyurea0.000533%
BADD_D01253Lenalidomide--
BADD_D01254Lenvatinib0.000799%
BADD_D01258Leucovorin0.011662%
BADD_D01281Levonorgestrel0.002085%
BADD_D01449Metronidazole0.000104%
BADD_D01567Nilotinib0.000533%
BADD_D01654Palbociclib0.000533%
BADD_D01687Pazopanib0.000533%
BADD_D01909Ramipril0.000799%
BADD_D01922Regorafenib0.000533%
BADD_D01933Ribavirin0.018131%
BADD_D01954Rivaroxaban--
BADD_D02029Sitagliptin0.000500%
BADD_D02058Sorafenib0.000533%
BADD_D02100Sunitinib0.000799%
BADD_D02105Tacrolimus0.007807%
BADD_D02139Tegaserod maleate--
BADD_D02236Tofacitinib0.001158%
BADD_D02373Warfarin0.000120%
BADD_D02514Etelcalcetide0.007228%
The 1th Page    1 2    Next   Last    Total 2 Pages